BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:41 PM
 | 
May 30, 2007
 |  BC Extra  |  Company News

EMEA accepts telavancin MAA

EMEA accepted for review an MAA from Astellas (Tokyo:4503) for telavancin to treat complicated skin...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >